The progression of cell death affects the rejection of allogeneic tumors in immune-competent mice - implications for cancer therapy

Frontiers in Immunology

Volumn 5, Issue NOV, 2014, Pages

  Chaurio, Ricardo A ^a   Muñoz, Luis E ^a   Maueröder, Christian ^a   Janko, Christina ^b   Harrer, Thomas ^a   Fürnrohr, Barbara G ^a,c   Niederweis, Michael ^d   Bilyy, Rostyslav ^e   Schett, Georg ^a   Herrmann, Martin ^a   Berens, Christian ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e INSTITUTE OF CELL BIOLOGY   (Ukraine)

Author keywords

Apoptosis; Cancer; Caspase 3; DAMPs; Immunogenicity; Necrosis; ROS; tBid

Indexed keywords

CASPASE 3; CYTOTOXIC FACTOR; DOXYCYCLINE; REACTIVE OXYGEN METABOLITE;

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GRAFT; CANCER THERAPY; CELL DEATH; CELL STRESS; CELL VIABILITY; DISEASE COURSE; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR CELL INOCULATION; TUMOR GROWTH; ULTRAVIOLET B RADIATION;

EID: 84919434277     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00560     Document Type: Article

References (56)

1. Matzinger P. The danger model: a renewed sense of self. Science (2002) 296(5566):301-5. doi:10.1126/science.1071059
2. Schroppel B, Legendre C. Delayed kidney graft function: from mechanism to translation. Kidney Int (2014) 86:251-8. doi:10.1038/ki.2014.18
3. Green DR, Ferguson T, Zitvogel L, Kroemer G. Immunogenic and tolerogenic cell death. Nat Rev Immunol (2009) 9(5):353-63. doi:10.1038/nri2545
4. Kepp O, Senovilla L, Kroemer G. Immunogenic cell death inducers as anticancer agents. Oncotarget (2014) 5(14):5190-1.
5. Kelland LR. Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development. Eur J Cancer (2004) 40(6):827-36. doi:10.1016/j.ejca.2003.11.028
6. Kepp O, Galluzzi L, Martins I, Schlemmer F, Adjemian S, Michaud M, et al. Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy. Cancer Metastasis Rev (2011) 30(1):61-9. doi:10.1007/s10555-011-9273-4
7. Maueroder C, Chaurio RA, Platzer S, Munoz LE, Berens C. Model systems for rapid and slow induction of apoptosis obtained by inducible expression of pro-apoptotic proteins. Autoimmunity (2013) 46(5):329-35. doi:10.3109/08916934.2012.752463
8. Danilchanka O, Sun J, Pavlenok M, Maueröder C, Speer A, Siroy A, et al. An outer membrane channel protein of Mycobacterium tuberculosis with exotoxin activity. Proc Natl Acad Sci U S A (2014) 111:6750-5. doi:10.1073/pnas.1400136111
9. Munoz LE, Maueroder C, Chaurio R, Berens C, Herrmann M, Janko C. Colourful death: six-parameter classification of cell death by flow cytometry - dead cells tell tales. Autoimmunity (2013) 46(5):336-41. doi:10.3109/08916934.2012.755960
10. United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) guidelines for the welfare of animals in experimental neoplasia (second edition). Br J Cancer (1998) 77(1):1-10. doi:10.1038/bjc.1998.1
11. Jones-Bolin S. Guidelines for the care and use of laboratory animals in biomedical research. Curr Protoc Pharmacol (2012) 59:4B:A.4B.1-9. doi:10.1002/0471141755.pha04bs59
12. Vale C, Stewart L, Tierney J. Trends in UK cancer trials: results from the UK coordinating committee for cancer research national register of cancer trials. Br J Cancer (2005) 92(5):811-4. doi:10.1038/sj.bjc.6602425
13. Janko C, Munoz L, Chaurio R, Maueroder C, Berens C, Lauber K, et al. Navigation to the graveyard-induction of various pathways of necrosis and their classification by flow cytometry. Methods Mol Biol (2013) 1004:3-15. doi:10.1007/978-1-62703-383-1_1
14. Turk MJ, Guevara-Patino JA, Rizzuto GA, Engelhorn ME, Sakaguchi S, Houghton AN. Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells. J Exp Med (2004) 200(6):771-82. doi:10.1084/jem.20041130
15. Appelt U, SheriffA, Gaipl US, Kalden JR, Voll RE, Herrmann M. Viable, apoptotic and necrotic monocytes expose phosphatidylserine: cooperative binding of the ligand annexin V to dying but not viable cells and implications for PS-dependent clearance. Cell Death Differ (2005) 12(2):194-6. doi:10.1038/sj.cdd.4401527
16. Franz S, Frey B, SheriffA, Gaipl US, Beer A, Voll RE, et al. Lectins detect changes of the glycosylation status of plasma membrane constituents during late apoptosis. Cytometry A (2006) 69(4):230-9. doi:10.1002/cyto.a.20206
17. Zhang G, Gurtu V, Kain SR, Yan G. Early detection of apoptosis using a fluorescent conjugate of annexin V. Biotechniques (1997) 23(3):525-31.
18. Saelens X, Festjens N, Vande Walle L, van Gurp M, van Loo G, Vandenabeele P. Toxic proteins released from mitochondria in cell death. Oncogene (2004) 23(16):2861-74. doi:10.1038/sj.onc.1207523
19. Troiano L, Ferraresi R, Lugli E, Nemes E, Roat E, Nasi M, et al. Multiparametric analysis of cells with different mitochondrial membrane potential during apoptosis by polychromatic flow cytometry. Nat Protoc (2007) 2(11):2719-27. doi:10.1038/nprot.2007.405
20. Frey B, Schildkopf P, Rodel F, Weiss EM, Munoz LE, Herrmann M, et al. AnnexinA5 renders dead tumor cells immunogenic - implications for multimodal cancer therapies. J Immunotoxicol (2009) 6(4):209-16. doi:10.3109/15476910903204058
21. Gaipl US, Munoz LE, Rodel F, Pausch F, Frey B, Brachvogel B, et al. Modulation of the immune system by dying cells and the phosphatidylserine-ligand annexin A5. Autoimmunity (2007) 40(4):254-9. doi:10.1080/08916930701357331
22. Munoz LE, Frey B, Pausch F, Baum W, Mueller RB, Brachvogel B, et al. The role of annexin A5 in the modulation of the immune response against dying and dead cells. Curr Med Chem (2007) 14(3):271-7. doi:10.2174/092986707779941131
23. Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell (1998) 94(4):491-501. doi:10.1016/S0092-8674(00)81590-1
24. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell (1998) 94(4):481-90. doi:10.1016/S0092-8674(00)81589-5
25. Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol cell Biol (2008) 9(1):47-59. doi:10.1038/nrm2308
26. Spencer SL, Gaudet S, Albeck JG, Burke JM, Sorger PK. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature (2009) 459(7245):428-32. doi:10.1038/nature08012
27. Eastman A. Apoptosis: a product of programmed and unprogrammed cell death. Toxicol Appl Pharmacol (1993) 121(1):160-4. doi:10.1006/taap.1993.1141
28. Lieberthal W, Triaca V, Levine J. Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis. Am J Physiol (1996) 270(4 Pt 2):F700-8.
29. Martin SJ, Green DR. Protease activation during apoptosis: death by a thousand cuts? Cell (1995) 82(3):349-52. doi:10.1016/0092-8674(95)90422-0
30. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol (2007) 35(4):495-516. doi:10.1080/01926230701320337
31. Shelton SN, Shawgo ME, Robertson JD. Cleavage of Bid by executioner caspases mediates feed forward amplification of mitochondrial outer membrane permeabilization during genotoxic stress-induced apoptosis in Jurkat cells. J Biol Chem (2009) 284(17):11247-55. doi:10.1074/jbc. M809392200
32. Patrick MH. Studies on thymine-derived UV photoproducts in DNA - I. Formation and biological role of pyrimidine adducts in DNA. Photochem Photobiol (1977) 25(4):357-72. doi:10.1111/j.1751-1097.1977.tb07355.x
33. Aragane Y, Kulms D, Metze D, Wilkes G, Poppelmann B, Luger TA, et al. Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95L. J Cell Biol (1998) 140(1):171-82. doi:10.1083/jcb.140.1.171
34. Rehemtulla A, Hamilton CA, Chinnaiyan AM, Dixit VM. Ultraviolet radiation-induced apoptosis is mediated by activation of CD-95 (Fas/APO-1). J Biol Chem (1997) 272(41):25783-6. doi:10.1074/jbc.272.41.25783
35. Rosette C, Karin M. Ultraviolet light and osmotic stress: activation of the JNK cascade through multiple growth factor and cytokine receptors. Science (1996) 274(5290):1194-7. doi:10.1126/science.274.5290.1194
36. Garcia-Calvo M, Peterson EP, Leiting B, Ruel R, Nicholson DW, Thornberry NA. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J Biol Chem (1998) 273(49):32608-13. doi:10.1074/jbc.273.49.32608
37. Kulms D, Zeise E, Poppelmann B, Schwarz T. DNA damage, death receptor activation and reactive oxygen species contribute to ultraviolet radiation-induced apoptosis in an essential and independent way. Oncogene (2002) 21(38):5844-51. doi:10.1038/sj.onc.1205743
38. Schiller M, Blank N, Heyder P, Herrmann M, Gaipl US, Kalden JR, et al. Induction of apoptosis by spermine-metabolites in primary human blood cells and various tumor cell lines. Apoptosis (2005) 10(5):1151-62. doi:10.1007/s10495-005-1188-5
39. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, Blagosklonny MV, et al. Molecular definitions of cell death subroutines: recommendations of the nomenclature committee on cell death 2012. Cell Death Differ (2012) 19(1):107-20. doi:10.1038/cdd.2011.96
40. Casares N, Pequignot MO, Tesniere A, Ghiringhelli F, Roux S, Chaput N, et al. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med (2005) 202(12):1691-701. doi:10.1084/jem.20050915
41. Panaretakis T, Kepp O, Brockmeier U, Tesniere A, Bjorklund AC, Chapman DC, et al. Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EMBO J (2009) 28(5):578-90. doi:10.1038/emboj.2009.1
42. Zitvogel L, Kepp O, Senovilla L, Menger L, Chaput N, Kroemer G. Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway. Clin Cancer Res (2010) 16(12):3100-4. doi:10.1158/1078-0432.CCR-09-2891
43. Kepp O, Tesniere A, Schlemmer F, Michaud M, Senovilla L, Zitvogel L, et al. Immunogenic cell death modalities and their impact on cancer treatment. Apoptosis (2009) 14(4):364-75. doi:10.1007/s10495-008-0303-9
44. Kepp O, Tesniere A, Zitvogel L, Kroemer G. The immunogenicity of tumor cell death. Curr Opin Oncol (2009) 21(1):71-6. doi:10.1097/CCO.0b013e32831bc375
45. Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol (2008) 8(4):279-89. doi:10.1038/nri2215
46. Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer (2012) 12(12):860-75. doi:10.1038/nrc3380
47. LaLadoire S, Hannani D, Vetizou M, Locher C, Aymeric L, Apetoh L, et al. Cell-death-associated molecular patterns as determinants of cancer immunogenicity. Antioxid Redox Signal (2013) 20(7):1098-116. doi:10.1089/ars.2012.5133
48. Briles EB, Kornfeld S. Isolation and metastatic properties of detachment variants of B16 melanoma cells. J Natl Cancer Inst (1978) 60(6):1217-22.
49. Fidler IJ. Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res (1975) 35(1):218-24.
50. Melis MH, Simpson KL, Dovedi SJ, Welman A, MacFarlane M, Dive C, et al. Sustained tumour eradication after induced caspase-3 activation and synchronous tumour apoptosis requires an intact host immune response. Cell Death Differ (2013) 20(5):765-73. doi:10.1038/cdd.2013.8
51. Ricci JE, Gottlieb RA, Green DR. Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis. J Cell Biol (2003) 160(1):65-75. doi:10.1083/jcb.200208089
52. Ricci JE, Munoz-Pinedo C, Fitzgerald P, Bailly-Maitre B, Perkins GA, Yadava N, et al. Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain. Cell (2004) 117(6):773-86. doi:10.1016/j.cell.2004.05.008
53. Gehrke N, Mertens C, Zillinger T, Wenzel J, Bald T, Zahn S, et al. Oxidative damage of DNA confers resistance to cytosolic nuclease TREX1 degradation and potentiates STING-dependent immune sensing. Immunity (2013) 39(3):482-95. doi:10.1016/j.immuni.2013.08.004
54. Leadsham JE, Sanders G, Giannaki S, Bastow EL, Hutton R, Naeimi WR, et al. Loss of cytochrome c oxidase promotes RAS-dependent ROS production from the ER resident NADPH oxidase, Yno1p, in yeast. Cell Metab (2013) 18(2):279-86. doi:10.1016/j.cmet.2013.07.005
55. Murphy MP. Mitochondrial dysfunction indirectly elevates ROS production by the endoplasmic reticulum. Cell Metab (2013) 18(2):145-6. doi:10.1016/j.cmet.2013.07.006
56. Kepp O, Menger L, Vacchelli E, Locher C, Adjemian S, Yamazaki T, et al. Crosstalk between ER stress and immunogenic cell death. Cytokine Growth Factor Rev (2013) 24(4):311-8. doi:10.1016/j.cytogfr.2013.05.001